Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yangzi Zhang

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|November 5, 2019
Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal CancerShuai Li, Dezuo Dong, Jianhao Geng, et al.
Radiation Oncology (London, England)|October 1, 2024
Outcomes and failure patterns after chemoradiotherapy for locally advanced rectal cancer with positive lateral pelvic lymph nodes: a propensity score-matched analysisShuai Li, Maxiaowei Song, Jian Tie, et al.
Frontiers in Oncology|January 17, 2024
Retrospective cohort study for thrombocytopenia during concurrent chemoradiotherapy for rectal cancerYue Teng, Dapeng Ma, Yan Yan, et al.
Frontiers in Oncology|March 11, 2021
Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy Can Benefit the Locally Advanced Rectal Cancer Patients With Clinically Positive Lateral Pelvic Lymph NodeShuai Li, Yangzi Zhang, Yang Yu, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 5, 2023
The ypT may better predict the efficacy of neoadjuvant chemoradiotherapy than tumor regression grade in locally advanced rectal cancer patients diagnosed ypT1-4N0Yujun Cui, Xinzhi Liu, Shuai Li, et al.
Journal of Cancer Research and Clinical Oncology|April 4, 2024
Clinicopathological factors predict residual lymph node metastasis in locally advanced rectal cancer with ypT0-2 after neoadjuvant chemoradiotherapyYujun Cui, Maxiaowei Song, Jian Tie, et al.
Frontiers in Oncology|December 31, 2021
Corrigendum: Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy Can Benefit the Locally Advanced Rectal Cancer Patients with Clinically Positive Lateral Pelvic Lymph NodeShuai Li, Yangzi Zhang, Yang Yu, et al.
Cancer Control : Journal of the Moffitt Cancer Center|April 16, 2025
Pretreatment MRI Parameters and Neutrophil-to-Lymphocyte Ratio Could Predict the Long-Term Prognosis of Locally Advanced Rectal Cancer Patients With Pathological Complete Response after Neoadjuvant ChemoradiotherapyYujun Cui, Shuai Li, Jian Tie, et al.
Radiation Oncology (London, England)|August 7, 2019
Excluding the ischiorectal fossa irradiation during neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy followed by abdominoperineal resection decreases perineal complications in patients with lower rectal cancerMaxiaowei Song, Jianhao Geng, Lin Wang, et al.
Clinical and Translational Radiation Oncology|December 6, 2022
MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter studyYirong Xiang, Shuai Li, Hongzhi Wang, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|November 5, 2019
Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal CancerShuai Li, Dezuo Dong, Jianhao Geng, et al.
Radiation Oncology (London, England)|October 1, 2024
Outcomes and failure patterns after chemoradiotherapy for locally advanced rectal cancer with positive lateral pelvic lymph nodes: a propensity score-matched analysisShuai Li, Maxiaowei Song, Jian Tie, et al.
Frontiers in Oncology|January 17, 2024
Retrospective cohort study for thrombocytopenia during concurrent chemoradiotherapy for rectal cancerYue Teng, Dapeng Ma, Yan Yan, et al.
Frontiers in Oncology|March 11, 2021
Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy Can Benefit the Locally Advanced Rectal Cancer Patients With Clinically Positive Lateral Pelvic Lymph NodeShuai Li, Yangzi Zhang, Yang Yu, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 5, 2023
The ypT may better predict the efficacy of neoadjuvant chemoradiotherapy than tumor regression grade in locally advanced rectal cancer patients diagnosed ypT1-4N0Yujun Cui, Xinzhi Liu, Shuai Li, et al.
Journal of Cancer Research and Clinical Oncology|April 4, 2024
Clinicopathological factors predict residual lymph node metastasis in locally advanced rectal cancer with ypT0-2 after neoadjuvant chemoradiotherapyYujun Cui, Maxiaowei Song, Jian Tie, et al.
Frontiers in Oncology|December 31, 2021
Corrigendum: Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy Can Benefit the Locally Advanced Rectal Cancer Patients with Clinically Positive Lateral Pelvic Lymph NodeShuai Li, Yangzi Zhang, Yang Yu, et al.
Cancer Control : Journal of the Moffitt Cancer Center|April 16, 2025
Pretreatment MRI Parameters and Neutrophil-to-Lymphocyte Ratio Could Predict the Long-Term Prognosis of Locally Advanced Rectal Cancer Patients With Pathological Complete Response after Neoadjuvant ChemoradiotherapyYujun Cui, Shuai Li, Jian Tie, et al.
Radiation Oncology (London, England)|August 7, 2019
Excluding the ischiorectal fossa irradiation during neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy followed by abdominoperineal resection decreases perineal complications in patients with lower rectal cancerMaxiaowei Song, Jianhao Geng, Lin Wang, et al.
Clinical and Translational Radiation Oncology|December 6, 2022
MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter studyYirong Xiang, Shuai Li, Hongzhi Wang, et al.
Pageof 6